To include your compound in the COVID-19 Resource Center, submit it here.

J&J unit opts not to regain Furiex antibiotic

Janssen Pharmaceutica N.V. did not exercise an option to regain rights to antibiotic candidate

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE